These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 23533769)

  • 1. Stealth properties to improve therapeutic efficacy of drug nanocarriers.
    Salmaso S; Caliceti P
    J Drug Deliv; 2013; 2013():374252. PubMed ID: 23533769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stealth Coating of Nanoparticles in Drug-Delivery Systems.
    Fam SY; Chee CF; Yong CY; Ho KL; Mariatulqabtiah AR; Tan WS
    Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32325941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parameters influencing the stealthiness of colloidal drug delivery systems.
    Vonarbourg A; Passirani C; Saulnier P; Benoit JP
    Biomaterials; 2006 Aug; 27(24):4356-73. PubMed ID: 16650890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune-stealth polymeric coating on drug delivery nanocarriers: In vitro engineering and in vivo fate.
    Shafaei N; Khorshidi S; Karkhaneh A
    J Biomater Appl; 2023 Aug; 38(2):159-178. PubMed ID: 37480331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of stealth lipids in nanomedicine-based drug carriers.
    Rastogi M; Saha RN; Alexander A; Singhvi G; Puri A; Dubey SK
    Chem Phys Lipids; 2021 Mar; 235():105036. PubMed ID: 33412151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells.
    Oliveira AC; Raemdonck K; Martens T; Rombouts K; Simón-Vázquez R; Botelho C; Lopes I; Lúcio M; González-Fernández Á; Real Oliveira ME; Gomes AC; Braeckmans K
    Acta Biomater; 2015 Oct; 25():216-29. PubMed ID: 26225736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyphosphoester surfactants as general stealth coatings for polymeric nanocarriers.
    Bauer KN; Simon J; Mailänder V; Landfester K; Wurm FR
    Acta Biomater; 2020 Oct; 116():318-328. PubMed ID: 32937204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lubricant-entrenched slippery surface-based nanocarriers to avoid macrophage uptake and improve drug utilization.
    Yang C; Feng J; Liu Z; Jiang J; Wang X; Yang C; Chen HJ; Xie X; Shang L; Wang J; Peng Z
    J Adv Res; 2023 Jun; 48():61-74. PubMed ID: 36041690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Functionalized Photosensitive Polymeric Nanocarriers.
    Fernández M; Orozco J
    Polymers (Basel); 2021 Jul; 13(15):. PubMed ID: 34372067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona.
    Schöttler S; Landfester K; Mailänder V
    Angew Chem Int Ed Engl; 2016 Jul; 55(31):8806-15. PubMed ID: 27303916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinspired "Active" Stealth Magneto-Nanomicelles for Theranostics Combining Efficient MRI and Enhanced Drug Delivery.
    Zhang KL; Zhou J; Zhou H; Wu Y; Liu R; Wang LL; Lin WW; Huang G; Yang HH
    ACS Appl Mater Interfaces; 2017 Sep; 9(36):30502-30509. PubMed ID: 28812358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fate of Nanoparticles In Vivo and the Strategy of Designing Stealth Nanoparticle for Drug Delivery.
    Bao J; Zhang Q; Duan T; Hu R; Tang J
    Curr Drug Targets; 2021; 22(8):922-946. PubMed ID: 33461465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights on Development Aspects of Polymeric Nanocarriers: The Translation from Bench to Clinic.
    Tewari AK; Upadhyay SC; Kumar M; Pathak K; Kaushik D; Verma R; Bhatt S; Massoud EES; Rahman MH; Cavalu S
    Polymers (Basel); 2022 Aug; 14(17):. PubMed ID: 36080620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design attributes of long-circulating polymeric drug delivery vehicles.
    Beck-Broichsitter M; Nicolas J; Couvreur P
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt B):304-17. PubMed ID: 25857838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogen-mimetic stealth nanocarriers for drug delivery: a future possibility.
    Cavadas M; González-Fernández A; Franco R
    Nanomedicine; 2011 Dec; 7(6):730-43. PubMed ID: 21658473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Circulating Polymeric Nanoparticles for Gene/Drug Delivery.
    Hu J; Sheng Y; Shi J; Yu B; Yu Z; Liao G
    Curr Drug Metab; 2018; 19(9):723-738. PubMed ID: 29219050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational Design of Cancer Nanomedicine for Simultaneous Stealth Surface and Enhanced Cellular Uptake.
    Jin Q; Deng Y; Chen X; Ji J
    ACS Nano; 2019 Feb; 13(2):954-977. PubMed ID: 30681834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of fluorinated stealth poly(ε-caprolactone) nanocarriers.
    Bona BL; Lagarrigue P; Chirizzi C; Espinoza MIM; Pipino C; Metrangolo P; Cellesi F; Baldelli Bombelli F
    Colloids Surf B Biointerfaces; 2024 Feb; 234():113730. PubMed ID: 38176337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
    Gullotti E; Yeo Y
    Mol Pharm; 2009; 6(4):1041-51. PubMed ID: 19366234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.